Mesenchymoma of the liver in childhood: five-year survival after combined-modality treatment.
D002648:Child; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology* / Q000628:therapy; D008637:Mesenchymoma / Q000473:pathology* / Q000628:therapy
D004317:Doxorubicin